1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with methylprednisolone in 10 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (methylprednisolone) | Trials (methylprednisolone) | Recent Studies (post-2010) (methylprednisolone) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 20,247 | 2,602 | 5,317 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | methylprednisolone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.011 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.011 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.011 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.011 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chand, N; Diamantis, W; Nolan, K; Sofia, RD | 1 |
| Johnson, HG; McNee, ML | 1 |
| Harada, K; Katayama, K; Machida, Y; Obaishi, H; Sakuma, Y; Shimomura, N; Shirato, M; Tsunoda, H; Yamada, K; Yamatsu, I | 1 |
| Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T | 1 |
| Handley, DA; Havill, AM; Van Valen, RG | 1 |
| Mata, R; Muniain, MA; Pérez, JJ; Pozuelo, F; Rodríguez, MC; Rodríguez, MD; Romero, A | 1 |
| Braquet, P; Egido, J; Gonzalez, E; Hernando, L; Mampaso, F; Ortiz, A; Ramirez, F; Robles, A; Sanchez Crespo, M | 1 |
| Endo, S; Hirashima, Y; Takaba, M; Takaku, A | 1 |
| Dong, CK; Hao, QY; Qi, YN; Tan, MS; Tang, XS; Wang, W; Wang, YL; Yang, F; Yi, P | 1 |
| Hao, QY; Qi, YN; Tan, MS; Tang, XS; Wang, W; Wang, YL; Wu, XJ; Yang, F; Yi, P | 1 |
10 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and methylprednisolone
| Article | Year |
|---|---|
Inhibition of aeroallergen-induced bronchial eosinophilia by azelastine in guinea pigs.
Topics: Administration, Oral; Animals; Azepines; Bronchodilator Agents; Dose-Response Relationship, Drug; Guinea Pigs; Leukocyte Count; Leukocytes, Mononuclear; Male; Methylprednisolone; Phthalazines; Platelet Activating Factor; Pulmonary Eosinophilia; Theophylline; Triazoles | 1992 |
Granulocyte chemotaxis in the canine trachea: inhibition by lipid mediator antagonists and systemic inhibitors.
Topics: Animals; Chemotaxis, Leukocyte; Dogs; Female; Granulocytes; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukotriene B4; Lipid Peroxidation; Lipids; Male; Methylprednisolone; Platelet Activating Factor; Trachea | 1991 |
Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation.
Topics: Aerosols; Animals; Azepines; Bronchoalveolar Lavage Fluid; Eosinophils; Guinea Pigs; Leukocyte Count; Lung; Male; Methylprednisolone; Platelet Activating Factor; Triazoles | 1991 |
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles | 1991 |
Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412.
Topics: Allergens; Animals; Azepines; Bronchi; Bronchoalveolar Lavage Fluid; Eosinophils; Guinea Pigs; Histamine; Hypersensitivity; In Vitro Techniques; Isoquinolines; Male; Methylprednisolone; Platelet Activating Factor; Triazines; Triazoles; Vagotomy; Vagus Nerve | 1990 |
[Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)].
Topics: Agranulocytosis; Animals; Cell Aggregation; Complement System Proteins; Furans; Methylprednisolone; Methylprednisolone Hemisuccinate; Neutropenia; Platelet Activating Factor; Quinacrine; Rabbits; Zymosan | 1988 |
Role of platelet-activating factor in adriamycin-induced nephropathy in rats.
Topics: Animals; Doxorubicin; Kidney; Kidney Diseases; Male; Methylprednisolone; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1987 |
Administration of methylprednisolone acetate into the subdural cavity in an infant with subdural fluid collection. PAF is a good indicator of the efficacy of the treatment.
Topics: Anti-Inflammatory Agents; Biomarkers; Brain Diseases; Cardiac Surgical Procedures; Drainage; Female; Humans; Infant; Intracranial Pressure; Methylprednisolone; Methylprednisolone Acetate; Platelet Activating Factor; Postoperative Complications; Subdural Effusion; Tomography, X-Ray Computed | 1998 |
[Effects of decompression combined with electro-acupuncture on rat with acute severe upper cervical spinal cord compression injury].
Topics: Animals; Caspase 9; Decompression, Surgical; Electroacupuncture; Methylprednisolone; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Compression | 2018 |
[Effect of Buyanghuanwu decoction on the expression of platelet activating factor after acute spinal cord injury in rats].
Topics: Animals; Drugs, Chinese Herbal; Female; Methylprednisolone; Platelet Activating Factor; Random Allocation; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries | 2018 |